ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

AXSM Axsome Therapeutics Inc

75.94
1.14 (1.52%)
取引時間後
最終更新日: 05:52:24
15分遅延
名称 銘柄コード 市場 種別
Axsome Therapeutics Inc AXSM NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
1.14 1.52% 75.94 05:52:24
始値 安値 高値 終値 前日終値
75.00 73.31 77.98 75.94 74.80
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0706:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0621:09IHMARKETNEWSIndex Futures Point to Strong Monday Opening, Building on..
2024/5/0620:05EDGAR2Form 8-K - Current report
2024/5/0620:00GLOBEAxsome Therapeutics Reports First Quarter 2024 Financial..
2024/5/0120:00GLOBEAxsome Therapeutics Recognizes May as Mental Health..
2024/4/1520:00GLOBEAxsome Therapeutics Highlights Innovative Neuroscience..
2024/4/1020:00GLOBEAxsome Therapeutics to Report First Quarter 2024 Financial..
2024/4/0120:00GLOBEAxsome Therapeutics Initiates ENGAGE Phase 3 Trial of..
2024/3/2520:00GLOBEAxsome Therapeutics Announces Results of CRESCENDO..
2024/3/2519:30GLOBEAxsome Therapeutics Announces AXS-12 Achieves Primary..
2024/3/1920:00GLOBEAxsome Therapeutics Initiates PARADIGM Phase 3 Trial of..
2024/3/0521:00GLOBEAxsome Therapeutics to Present at the Leerink Partners..
2024/3/0108:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0108:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0107:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2721:00GLOBEAxsome Therapeutics to Present at the TD Cowen 44th Annual..
2024/2/2322:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2021:05EDGAR2Form 8-K - Current report
2024/2/2021:00GLOBEAxsome Therapeutics Reports Fourth Quarter and Full Year..
2024/2/2019:37IHMARKETNEWSMarket Cautiousness Ahead of Retail Giants’ Earnings; Oil..
2024/2/1505:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2321:00GLOBEAxsome Therapeutics to Report Fourth Quarter and Full Year..
2024/1/0821:10EDGAR2Form 8-K - Current report
2024/1/0421:11EDGAR2Form 8-K - Current report
2024/1/0421:00GLOBEAxsome Therapeutics Provides Preliminary Fourth Quarter and..
2023/12/1121:00GLOBEAxsome Therapeutics Presents New Data and Post-Hoc Analyses..
2023/12/0806:05EDGAR2Form 8-K - Current report
2023/12/0721:00GLOBEAxsome Therapeutics Hosts Solriamfetol Virtual Investor..
2023/11/2221:00GLOBEAxsome Therapeutics to Host Solriamfetol Virtual Investor..
2023/11/2121:00GLOBEAxsome Therapeutics to Present at the Piper Sandler 35th..
2023/11/0706:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0621:05EDGAR2Form 8-K - Current report
2023/11/0621:00GLOBEAxsome Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0620:54IHMARKETNEWSMonday’s Wall Street Highlights: Berkshire Hathaway, Tesla,..
2023/11/0220:00GLOBEAxsome Therapeutics and the Global Alzheimer’s Disease..
2023/10/3120:00GLOBEAxsome Therapeutics to Present at Upcoming Investor..
2023/10/2420:00GLOBEAxsome Therapeutics Presents Results of the ACCORD trial of..
2023/10/1206:03EDGAR2Form 8-K - Current report
2023/10/1120:00GLOBEAxsome Therapeutics Appoints Dr. Sue Mahony to its Board of..
2023/10/1020:00GLOBEAxsome Therapeutics to Report Third Quarter 2023 Financial..
2023/10/0220:00GLOBEAxsome Therapeutics Joins the National Alliance on Mental..
2023/9/2120:00GLOBEAxsome Therapeutics Joins the Global Narcolepsy Community in..
2023/9/1607:32EDGAR2Form 144 - Report of proposed sale of securities
2023/9/1607:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0720:03GLOBEAxsome Therapeutics Highlights Commitment to Innovating..
2023/9/0520:00GLOBEAxsome Therapeutics to Present at Three Upcoming Investor..
2023/8/1520:45EDGAR2Form 8-K - Current report
2023/8/0806:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0805:02EDGAR2Form 8-K - Current report
2023/8/0720:00GLOBEAxsome Therapeutics Reports Second Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock